DeepMed Research

Vanderbilt University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1873-01-01

Employees: 10K

Market Cap: -

Website: http://www.vanderbilt.edu

Clinical Trials

Efficacy of Lansoprazole in Chronic Post Nasal Drip

Phase 3

Completed

Conditions: Larynx Disease

Interventions: Drug: Lansoprazole Tablet
Procedure: PH and impedence testing
Procedure: manometry
Drug: placebo
Drug: lansoprazole

First Posted Date: 2006-06-09

Last Posted Date: 2012-08-21

Lead Sponsor: Vanderbilt University

Target Recruit Count: 75

Registration Number: NCT00335283

Locations: 🇺🇸
Vanderbilt University Medical Center, Vanderbilt Digestive Disease Clinic, TVC, Room 1660, Nashville, Tennessee, United States

Improving Care for Patients With Diabetes and Poor Numeracy Skills

Not Applicable

Completed

Conditions: Diabetes

Interventions: Behavioral: Control Group
Behavioral: Literacy/Numeracy oriented educational intervention

First Posted Date: 2006-04-06

Last Posted Date: 2008-02-18

Lead Sponsor: Vanderbilt University

Target Recruit Count: 106

Registration Number: NCT00311922

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Hydroxychloroquine in Cystic Fibrosis

Phase 1

Completed

Conditions: Cystic Fibrosis

First Posted Date: 2006-04-06

Last Posted Date: 2008-01-30

Lead Sponsor: Vanderbilt University

Target Recruit Count: 20

Registration Number: NCT00311883

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Tocopherols and Alpha Lipoic Acid Treatment Chronic Kidney Disease (TALAT)

Phase 2

Completed

Conditions: Chronic Kidney Disease

Interventions: Drug: Alpha, gamma, beta, and delta (mixed) tocopherols
Drug: placebo
Drug: alpha lipoic acid

First Posted Date: 2006-03-30

Last Posted Date: 2009-07-09

Lead Sponsor: Vanderbilt University

Target Recruit Count: 62

Registration Number: NCT00308971

Locations: 🇺🇸
Maine Medical Center, Portland, Maine, United States
🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?

Phase 4

Completed

Conditions: Schizoaffective Disorder
Schizophrenia

Interventions: Drug: divalproex sodium ER
Drug: placebo

First Posted Date: 2006-03-23

Last Posted Date: 2010-01-07

Lead Sponsor: Vanderbilt University

Target Recruit Count: 60

Registration Number: NCT00306475

Locations: 🇺🇸
Psychiatric Hospital at Vanderbilt, Nashville, Tennessee, United States

Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation

Phase 4

Completed

Conditions: Kidney Transplantation

First Posted Date: 2006-03-21

Last Posted Date: 2006-03-21

Lead Sponsor: Vanderbilt University

Target Recruit Count: 80

Registration Number: NCT00305396

Locations: 🇺🇸
Vanderbilt University Medical Center/Nashville VA, Nashville, Tennessee, United States

Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance Imaging

Not Applicable

Completed

Conditions: Schizoaffective Disorder
Hallucinations
Schizophrenia

Interventions: Device: functional magnetic resonance imaging

First Posted Date: 2006-02-07

Last Posted Date: 2017-04-19

Lead Sponsor: Vanderbilt University

Target Recruit Count: 60

Registration Number: NCT00288340

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Prevalence of Spasticity in Adults With Mental Retardation Living in the Community

Completed

Conditions: Mental Retardation
Spasticity

First Posted Date: 2006-01-25

Last Posted Date: 2008-03-28

Lead Sponsor: Vanderbilt University

Target Recruit Count: 7

Registration Number: NCT00282191

Locations: 🇺🇸
Homes, Davidson County, Tennessee, United States

Center for Reducing Asthma Disparities - Meharry/Vanderbilt Centers

Completed

Conditions: Asthma
Lung Diseases

First Posted Date: 2006-01-24

Last Posted Date: 2014-12-11

Lead Sponsor: Vanderbilt University

Target Recruit Count: 180

Registration Number: NCT00281151

Locations: 🇺🇸
Meharry Medical School, Nashville, Tennessee, United States
🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Botox vs. Baclofen for Upper Limb Spasticity

Phase 1

Terminated

Conditions: Spasticity

Interventions: Drug: intramuscular Botox versus oral baclofen

First Posted Date: 2006-01-20

Last Posted Date: 2012-01-20

Lead Sponsor: Vanderbilt University

Target Recruit Count: 8

Registration Number: NCT00280280

Locations: 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy